| scholarly article | Q13442814 |
| P50 | author | Abdellatif Bouazzaoui | Q61853431 |
| P2093 | author name string | Mohammad Athar | |
| Wajahatullah Khan | |||
| Zainularifeen Abduljaleel | |||
| Abulkareem Anazi | |||
| Burhan M Edrees | |||
| Faisal A Al-Allaf | |||
| Howaida Al-Edressi | |||
| Khawala Alansary | |||
| Mohiuddin M Taher | |||
| Muawia A Ahmed | |||
| Naffaa Al-Harbi | |||
| Naji Altayeb | |||
| Ramzia Safar | |||
| P2860 | cites work | The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein | Q24292750 |
| The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area | Q24310842 | ||
| PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells | Q24311878 | ||
| I-TASSER: a unified platform for automated protein structure and function prediction | Q24605680 | ||
| CHARMM: the biomolecular simulation program | Q24658108 | ||
| Novel allosteric sites on Ras for lead generation | Q27317333 | ||
| Structural view of a fungal toxin acting on a 14-3-3 regulatory complex | Q27640587 | ||
| Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features | Q27860675 | ||
| GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation | Q27860944 | ||
| Structures, alternative splicing, and neurexin binding of multiple neuroligins | Q28274307 | ||
| Neuroligin 1: a splice site-specific ligand for beta-neurexins | Q29614429 | ||
| SNPs, protein structure, and disease. | Q30328103 | ||
| Mapping SNPs to protein sequence and structure data. | Q30349871 | ||
| Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie | Q33595575 | ||
| Towards a structural basis of human non-synonymous single nucleotide polymorphisms | Q33899435 | ||
| Molecular diagnostics for autosomal dominant polycystic kidney disease | Q34100184 | ||
| Targeting the proangiogenic VEGF-VEGFR protein-protein interface with drug-like compounds by in silico and in vitro screening | Q34111157 | ||
| Genetics and pathogenesis of polycystic kidney disease. | Q34145624 | ||
| SNAP: predict effect of non-synonymous polymorphisms on function | Q34631704 | ||
| Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology | Q34746312 | ||
| Comprehensive in silico mutagenesis highlights functionally important residues in proteins | Q34806039 | ||
| In silico mutagenesis: a case study of the melanocortin 4 receptor | Q34979349 | ||
| The severe perinatal form of autosomal recessive polycystic kidney disease maps to chromosome 6p21.1-p12: implications for genetic counseling. | Q35644199 | ||
| PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats | Q35764727 | ||
| Identification of rare cancer driver mutations by network reconstruction | Q37363146 | ||
| Next-generation sequencing for molecular diagnosis of autosomal recessive polycystic kidney disease | Q38444988 | ||
| Free energy via molecular simulation: applications to chemical and biomolecular systems | Q38648060 | ||
| Unified criteria for ultrasonographic diagnosis of ADPKD. | Q41829694 | ||
| Autosomal Recessive Polycystic Kidney Disease: The Clinical Experience in North America | Q44503166 | ||
| Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene | Q48286475 | ||
| Fast and accurate predictions of protein stability changes upon mutations using statistical potentials and neural networks: PoPMuSiC-2.0. | Q50602336 | ||
| Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease (ARPKD) | Q57908853 | ||
| Genotype–phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease | Q59619315 | ||
| Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease | Q68642512 | ||
| Computerized tomography and ultrasound in the diagnosis of cerebro-hepato-renal syndrome of Zellweger | Q68946084 | ||
| Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21-cen | Q72703024 | ||
| Predicting protein stability changes upon mutation using database-derived potentials: solvent accessibility determines the importance of local versus non-local interactions along the sequence | Q73702777 | ||
| How segmental duplications shape our genome: recent evolution of ABCC6 and PKD1 Mendelian disease genes | Q81963903 | ||
| Fixing the front end | Q82255339 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 127-134 | |
| P577 | publication date | 2016-11-03 | |
| P1433 | published in | Genomics Data | Q27725685 |
| P1476 | title | Functional alterations due to amino acid changes and evolutionary comparative analysis of ARPKD and ADPKD genes | |
| P478 | volume | 10 |
| Q90929271 | A rare deep intronic mutation of PKHD1 gene, c.8798-459 C > A, causes autosomal recessive polycystic kidney disease by pseudoexon activation |
| Q39375147 | Dolichol phosphate mannose synthase: a Glycosyltransferase with Unity in molecular diversities. |
| Q93128241 | Exome sequencing of Saudi Arabian patients with ADPKD |
| Q64269744 | Identification of a pathogenic mutation in a Chinese pedigree with polycystic kidney disease |
Search more.